The Head of Sanofi-Genzyme’s Czech & Slovak affiliate points out that his affiliate generates a third of the regional turnover for the group as rules and regulations in his market resemble a paradise in regional comparison. The high commitment to patients is highlighted as a fundamental reason for this success!
Mr. Korbel, could you please briefly introduce yourself and your background to our executive readership around the world?
The Czech Republic, in terms of sophistication of rules and regulations, market access, and transparency, is a paradise in comparison with the other countries included in our region.
